H. Ohno

Yokohama City University

Health Outcomes Studied

• Increased Fecal Butyrate Levels

Papers (13)

• 2021
  Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis10.1371/journal.pone.0248584
• 2020
  Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action10.12938/bmfh.2019-022
• 2020
  The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin10.1080/19490976.2020.1758290
• 2018
  Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats10.1038/s41598-018-30943-3
• 2017
  Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors10.1371/journal.pone.0173979
• 2015
  Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community10.1038/srep13548
• 2014
  Lactobacillus acidophilus L-92 Cells Activate Expression of Immunomodulatory Genes in THP-1 Cells10.12938/bmfh.33.157
• 2012
  Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters10.4161/gmic.21214
• 2012
  Exposure to probiotic Lactobacillus acidophilus L-92 modulates gene expression profiles of epithelial Caco-2 cells.10.1089/jmf.2012.0040
• 2011
  Bifidobacteria can protect from enteropathogenic infection through production of acetate10.1038/nature09646
• 2010
  Effects of Bifidobacterium bifidum G9-1 on Nasal Symptoms in a Guinea Pig Model of Experimental Allergic Rhinitis10.12938/bifidus.30.1
• 2008
  Comparative Genome Analysis of Lactobacillus reuteri and Lactobacillus fermentum Reveal a Genomic Island for Reuterin and Cobalamin Production10.1093/dnares/dsn009
• 2005Primary author
  Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice.10.1248/BPB.28.1462